EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Rosacea, microbiome and probiotics: the gut-skin axis

Pedro Sánchez-Pellicer, Cristina Eguren-Michelena, Juan García-Gavín, Mar Llamas-Velasco, Laura Navarro-Moratalla, Eva Núñez-Delegido, Juan Agüera-Santos, Vicente Navarro-López

Frontiers in Microbiology · 08.01.2024 · 14

DOI: 10.3389/fmicb.2023.1323644 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Microbiology, online erschienen am 08.01.2024. Verfasst von Pedro Sánchez-Pellicer und 7 weiteren Autor:innen. Beteiligte Einrichtung: MiBioPath Research Group, Faculty of Medicine, Catholic University of Murcia (UCAM), Guadalupe, Spain. Die Arbeit wurde bisher 59-mal zitiert (Crossref) und nennt 140 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rosacea is an inflammatory skin disease involving diverse symptoms with a variable clinical progress which can severely impact the patient’s quality of life as well as their mental health. The pathophysiological model of rosacea involves an unbalanced immune system predisposed to excessive inflammation, in addition to vascular and nervous alterations, being certain cutaneous microorganisms’ triggers of the symptoms onset. The gut-skin axis explains a bidirectional interaction between skin and gut microbiota in some inflammatory skin diseases such as atopic dermatitis, psoriasis, or rosacea. The introduction and consolidation of the next-generation sequencing in recent years has provided unprecedented information about the microbiome. However, the characterization of the gut and skin microbiota and the impact of the gut-skin axis in patients with rosacea has been little explored, in contrast to other inflammatory skin diseases such as atopic dermatitis or psoriasis. Furthermore, the clinical evolution of patients with rosacea is not always adequate and it is common for them to present a sustained symptomatology with frequent flare-ups. In this context, probiotic supplementation could improve the clinical evolution of these patients as happens in other pathologies. Through this review we aim to establish and compile the basics and directions of current knowledge to understand the mechanisms by which the microbiome influences the pathogenesis of rosacea, and how modulation of the skin and gut microbiota could benefit these patients.

Schlagwörter

Stichwörter der Autor:innen

gut microbiotagut-skin axismicrobiomeprobioticrosaceaskin microbiota

Autor:innen und Institutionen

  • MiBioPath Research Group, Faculty of Medicine, Catholic University of Murcia (UCAM), Guadalupe, Spain.
  • Eguren Dermatology and Aesthetics Clinic, Madrid, Spain.
  • Gavín Dermatologists Clinic, Vigo, Spain.
  • Department of Dermatology, Hospital Universitario de La Princesa, Madrid, Spain.
  • Infectious Diseases Unit, Department of Internal Medicine, University Hospital of Vinalopó-Fisabio, Elche, Spain.

Zitieren

APA

Sánchez-Pellicer, P., Eguren-Michelena, C., García-Gavín, J., Llamas-Velasco, M., Navarro-Moratalla, L., Núñez-Delegido, E., Agüera-Santos, J., & Navarro-López, V. (2024). Rosacea, microbiome and probiotics: the gut-skin axis. Frontiers in Microbiology, 14. https://doi.org/10.3389/fmicb.2023.1323644

Vancouver

Sánchez-Pellicer P, Eguren-Michelena C, García-Gavín J, Llamas-Velasco M, Navarro-Moratalla L, Núñez-Delegido E, et al. Rosacea, microbiome and probiotics: the gut-skin axis. Frontiers in Microbiology. 2024;14. doi:10.3389/fmicb.2023.1323644

BibTeX
@article{SnchezPellicer2024,
  author = {Sánchez-Pellicer, Pedro and Eguren-Michelena, Cristina and García-Gavín, Juan and Llamas-Velasco, Mar and Navarro-Moratalla, Laura and Núñez-Delegido, Eva and Agüera-Santos, Juan and Navarro-López, Vicente},
  title = {Rosacea, microbiome and probiotics: the gut-skin axis},
  journal = {Frontiers in Microbiology},
  year = {2024},
  volume = {14},
  doi = {10.3389/fmicb.2023.1323644}
}
Kostenlos starten →